Although the evidence presented herein strongly supports the existence of an integrated mechanism between glycosylation modifications and insulin/IGF system in cancer cells, it is worth mentioning that some controversial data exist due to the fact that the effects of N-glycans are cell/tissue/organ-specific. Here, IGF1 is linked to cancer.